In a small study, the gamified mobile app helped adults with MS manage daily fatigue by becoming more aware of their changing ...

Nearly 50% of MS patients report pronounced fatigue, which has a significantly negative impact on their well-being, a Finnish ...

Observational studies and two randomized controlled trials consistently suggest that, in general, disease recurrence after ...

A growing body of research is uncovering connections between aluminium accumulation in the brain and the progression of ...

Varied approaches to remote patient monitoring are in development to close care gaps between patients and rheumatologists, ...

Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis If approved, tolebrutinib would be the first and only brain-penetrant BTK inhibitor to ...

Powys politicians have slammed Powys Teaching Health Board for unanimously choosing to artificially increase waiting times ...

A new clinical trial has shown for the first time that taking high doses of vitamin D could stave off the progression of ...

If approved, SNY's tolebrutinib will be the first therapy to target smoldering neuroinflammation, a key driver of disability ...

Known as phage therapy, it uses viruses to kill harmful bacteria in difficult-to-treat infections. Read more at ...

Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis If approved, tolebrutinib would be the first and only brain-penetrant BTK inhibitor to ...

Discover how gut bacteria may influence multiple sclerosis progression and severity. Research reveals specific bacterial ...